Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by standudu
Group name EquipeAT
Item Type Journal Article
Title Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo
Creator Lamour et al.
Author Virginie Lamour
Author Aurélie Henry
Author Jérôme Kroonen
Author Marie-Julie Nokin
Author Zofia von Marschall
Author Larry W. Fisher
Author Tieu-Lan Chau
Author Alain Chariot
Author Marc Sanson
Author Jean-Yves Delattre
Author Andrei Turtoi
Author Olivier Peulen
Author Bernard Rogister
Author Vincent Castronovo
Author Akeila Bellahcène
Abstract Osteopontin (OPN) is a secreted protein involved in most aspects of tumor progression and metastasis development. Elevated OPN expression has been reported in multiple types of cancer including glioblastoma (GBM), the highest grade and most aggressive brain tumor. GBMs contain a subpopulation of glioma-initiating cells (GICs) implicated in progression, therapeutic resistance and recurrence. We have previously demonstrated that OPN silencing inhibited GBM cell growth in vitro and in vivo. Moreover, activation of CD44 signaling upon OPN ligation has been recently implicated in the acquisition of a stem cell phenotype by GBM cells. The present study is aimed to explore OPN autocrine function using shRNA silencing strategy in GICs enriched from GBM cell lines and a human primary GBM grown in EGF and bFGF defined medium. The removal of these growth factors and addition of serum induced a significant loss of OPN expression in GICs. We showed that OPN-silenced GICs were unable to grow as spheres and this capacity was restored by exogenous OPN. Importantly, the expression of Sox2, Oct3/4 and Nanog, key stemness transcription factors, was significantly decreased in GICs upon OPN targeting. We identified Akt/mTOR/p70S6K as the main signaling pathway triggered following OPN-mediated EGFR activation in GICs. Finally, in an orthotopic xenograft mouse model, the tumorigenic potential of U87-MG sphere cells was completely abrogated upon OPN silencing. Our demonstration of endogenous OPN major regulatory effects on GICs stemness phenotype and tumorigenicity implies a greater role than anticipated for OPN in GBM pathogenesis from initiation and progression to probable recurrence.
Publication International Journal of Cancer
Volume 137
Issue 5
Pages 1047-1057
Date Sep 01, 2015
Journal Abbr Int. J. Cancer
Language eng
DOI 10.1002/ijc.29454
ISSN 1097-0215
Library Catalog PubMed
Extra PMID: 25620078
Tags Animals, Autocrine Communication, Brain Neoplasms, Cell Line, Tumor, Cell Proliferation, EGFR, Gene Silencing, glioblastoma, Humans, Mice, Mice, Nude, Molecular Targeted Therapy, Neoplasm Transplantation, Neoplastic Stem Cells, original, Osteopontin, RNA, Small Interfering, Sox2, Spheroids, Cellular, tumor initiating cells
Date Added 2019/05/29 - 16:14:23
Date Modified 2019/05/29 - 16:14:31
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés